Mr. Davidson is a Vice President in Houlihan Lokey’s Healthcare Group, where he primarily covers the pharma services and commercialization industry. His responsibilities include working on sellside and buyside M&A advisory engagements. Mr. Davidson is based in the firm’s New York office.
Mr. Davidson’s notable transactions include advising Red Nucleus on its sale to THL Partners; Avant on its sale to Real Chemistry; Spectrum Science on its investment from Knox Lane; OPEN Health on its sale to Astorg; Fishawack Health (NKA Avalere Health) on its acquisition of Avalere Health; Novo Holdings on its acquisition of Medical Knowledge Group; Intouch Group on its sale to Eversana; The Lockwood Group on its investment from Ares; and BGB Group on its investment from TPG.
Prior to joining Houlihan Lokey, Mr. Davidson worked at Truist Securities, where he focused on M&A and debt and equity financings.
Mr. Davidson holds a B.A. in Finance, with a second major in Government, from Wofford College.